Sprinklr Announces Second Quarter Fiscal 2025 Results

Go back to Sprinklr Announces Second Quarter Fiscal 2025 Results
Cardium Therapeutics, Inc. (NYSE: CXM) Delayed: 7.20 --0 (-0%)
Previous Close $7.20    52 Week High $1.44 
Open $7.20    52 Week Low $0.06 
Day High $7.20    P/E N/A 
Day Low $7.20    EPS $-1.24 
Volume 523